Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry

CONCLUSION: The initial use of MME DMTs was among the strongest predictors of DMT discontinuation in a large German retrospective MS cohort, arguing for the need for prospective treatment strategy trials, not only but also on the initial broad use of HE DMTs in PwMS.PMID:38560408 | PMC:PMC10981260 | DOI:10.1177/17562864241239740

Source: Adv Data - April 1, 2024 Category: Epidemiology Authors: Niklas Frahm David Ellenberger Alexander Stahmann Firas Fneish Daniel L üftenegger Hans C Salmen Ksenija Schirduan Tom P A Schaak Peter Flachenecker Christoph Kleinschnitz Friedemann Paul Dagmar Krefting Uwe K Zettl Melanie Peters Clemens Warnke Source Type: research